{"organizations": [], "uuid": "b1ddd31e76f929feeba8cda6d8471aaeb76e1483", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-conatus-pharmaceuticals-q1-revenue/brief-conatus-pharmaceuticals-q1-revenue-9-7-million-idUSASC09Z47", "country": "US", "domain_rank": 408, "title": "BRIEF-Conatus Pharmaceuticals Q1 Revenue $9.7 Million", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-02T23:18:00.000+03:00", "replies_count": 0, "uuid": "b1ddd31e76f929feeba8cda6d8471aaeb76e1483"}, "author": "", "url": "https://www.reuters.com/article/brief-conatus-pharmaceuticals-q1-revenue/brief-conatus-pharmaceuticals-q1-revenue-9-7-million-idUSASC09Z47", "ord_in_thread": 0, "title": "BRIEF-Conatus Pharmaceuticals Q1 Revenue $9.7 Million", "locations": [], "entities": {"persons": [{"name": "conatus pharmaceuti", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters staff", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " Conatus Pharmaceuticals Q1 Revenue $9.7 Million Reuters Staff\nMay 2 (Reuters) - Conatus Pharmaceuticals Inc:\n* CONATUS PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROGRAM UPDATES * QTRLY LOSS PER SHARE $0.17\n* Q1 EARNINGS PER SHARE VIEW $-0.17 â€” THOMSON REUTERS I/B/E/S ", "external_links": [], "published": "2018-05-02T23:18:00.000+03:00", "crawled": "2018-05-02T23:34:40.003+03:00", "highlightTitle": ""}